Doctors Note Logo

Published on: 5/6/2026

How does PRP for glaucoma save your sight? The reality and medically approved next steps.

Panretinal photocoagulation (PRP) treats neovascular glaucoma by using targeted peripheral retinal laser to reduce ischemia-driven VEGF production. This causes abnormal iris and angle blood vessels to regress, reopens the drainage angle, lowers intraocular pressure (IOP), and prevents synechiae—helping preserve vision. PRP is an outpatient procedure commonly combined with anti-VEGF injections and IOP-lowering medications to stabilize retinal disease and reduce the need for surgery.

Key considerations include the risk of peripheral vision loss, the importance of thorough evaluation and follow-up, and the potential need for additional treatments.

Because glaucoma symptoms can overlap with other serious eye conditions—and early detection dramatically improves outcomes—it's worth understanding what your specific symptoms may indicate before your next appointment. Take a free, instant, online symptom check to clarify what's going on and confidently navigate your next steps.

Reviewed for medical accuracy: 07/09/2026

answer background

Explanation

How PRP for Glaucoma Saves Your Sight: Reality and Medically Approved Next Steps

Glaucoma is a leading cause of irreversible vision loss. In a subtype called neovascular glaucoma, new, fragile blood vessels grow on the iris and drainage angle, blocking fluid outflow and raising intraocular pressure (IOP). Pan-retinal photocoagulation (PRP for glaucoma) is an established laser treatment that can halt this process and help preserve your vision.

What Is PRP for Glaucoma?

• Pan-retinal photocoagulation (PRP) uses laser burns across the peripheral retina
• It is primarily indicated in proliferative diabetic retinopathy or retinal vein occlusion—conditions that fuel neovascular glaucoma
• By treating a large retinal area, PRP reduces the retina's oxygen demand and cuts production of vascular endothelial growth factor (VEGF), the key driver of unwanted new blood vessels

How PRP Works to Preserve Sight

  1. VEGF Reduction
    • Ischemic retina produces excess VEGF
    • PRP destroys patches of peripheral retina, lowering VEGF levels
    • Existing abnormal vessels regress, and new growth slows

  2. Pressure Control
    • Neovascular membranes in the drainage angle block fluid outflow
    • As vessels shrink, the angle re-opens slightly, improving IOP
    • Lower IOP means less stress on the optic nerve

  3. Preventing Synechiae
    • Fibrous tissue can form permanent adhesions (synechiae) that seal the angle
    • Early PRP reduces inflammation and vessel proliferation, preventing angle closure

Benefits of PRP for Glaucoma

  • Rapid regression of iris and angle neovascularization
  • Decreased need for glaucoma surgery in some cases
  • Stabilization of retinal disease that threatens central vision
  • Integration with anti-VEGF injections for a combined approach
  • Outpatient procedure with minimal discomfort

What to Expect During and After PRP

  1. Pre-Treatment Evaluation

    • Comprehensive eye exam including IOP measurement and retinal imaging
    • Discussion of your medical history (especially diabetes control)
  2. Procedure

    • Topical anesthesia (eye drops) or mild sedation
    • 15–30 minutes of laser applications to the peripheral retina
    • You may feel mild discomfort or flashing lights
  3. Post-Treatment Care

    • Anti-inflammatory eye drops for 1–2 weeks
    • Possible temporary increase in IOP—monitoring is essential
    • Follow-up visits at 1 week, 1 month, and as advised

Risks and Considerations

While PRP is generally safe, it carries some risks:

  • Peripheral visual field loss or night-vision difficulty
  • Temporary swelling or inflammation
  • Rarely, macular edema (swelling at the central retina)
  • Possible need for repeat treatments if ischemia persists

Your eye specialist will balance these risks against the threat of irreversible glaucoma-related vision loss.

Medically Approved Next Steps

  1. Comprehensive Evaluation

    • Confirm neovascular glaucoma diagnosis with gonioscopy, OCT, and fluorescein angiography
    • Assess overall eye health and coexisting diabetic or vascular conditions
  2. Medical Management

    • Start or adjust IOP-lowering eye drops (prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors)
    • Optimize systemic control of diabetes and hypertension
  3. Anti-VEGF Therapy

    • Intravitreal injections (bevacizumab, ranibizumab, aflibercept) to rapidly shrink neovessels
    • Often combined with PRP for sustained VEGF suppression
  4. Laser Treatment (PRP for Glaucoma)

    • Schedule PRP promptly to address widespread ischemia
    • Tailor laser intensity and spot count to individual retinal findings
  5. Surgical Options

    • If IOP remains uncontrolled, consider glaucoma drainage devices or cyclophotocoagulation
    • Trabeculectomy is less favored in neovascular cases due to higher failure rates
  6. Lifelong Monitoring

    • Regular IOP checks, visual field testing, and retinal exams
    • Early detection of complications or disease progression

When to Seek Immediate Help

Even with PRP and medical therapy, neovascular glaucoma can worsen. Contact your eye doctor if you experience:

  • Sudden vision loss or severe eye pain
  • Redness, light sensitivity, or new floaters
  • Headache combined with blurry vision

If you notice any of these warning signs or other concerning changes in your vision, use Ubie's free AI Symptom Checker to quickly assess your symptoms and receive guidance on the urgency of care you may need.

Speak to a Doctor

PRP for glaucoma is a powerful tool to save sight in neovascular cases, but individual treatment plans vary. Always speak to a doctor about any eye symptoms that could signal serious or sight-threatening problems. Early diagnosis and a coordinated care approach offer the best chance to preserve your vision.

(References)

  • * Alio JL, et al. Therapeutic potential of platelet-rich plasma in ophthalmology: a systematic review. Eye (Lond). 2017 Jul;31(7):1001-1011. doi: 10.1038/eye.2017.38. Epub 2017 Mar 24. PMID: 28338686.

  • * Aftab U, et al. Platelet-rich plasma: a novel therapy for neurodegenerative diseases of the eye? Neural Regen Res. 2021 May;16(5):989-994. doi: 10.4103/1673-5374.301018. PMID: 33269784.

  • * Park DY, et al. Neuroprotective effects of platelet-rich plasma against oxidative stress-induced retinal ganglion cell damage. Exp Eye Res. 2020 Jan;190:107875. doi: 10.1016/j.exer.2019.107875. Epub 2019 Nov 13. PMID: 31733364.

  • * Shen T, et al. Clinical application of platelet-rich plasma in ophthalmology. Biomed Res Int. 2021 Dec 21;2021:5548325. doi: 10.1155/2021/5548325. eCollection 2021. PMID: 34966779.

  • * Zhang Y, et al. Platelet-Rich Plasma in Ophthalmology: Recent Advances and Future Directions. J Ophthalmol. 2023 Feb 15;2023:6630040. doi: 10.1155/2023/6630040. eCollection 2023. PMID: 36824982.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.